爆炸性新闻，大略停打第一针阿斯利康了，实锤儿脑血栓
- 主题发起人 Jay Wang
- 开始时间
这边要想获得及时检查，得夸大你自己的症状，千万别逞强。
就这情况，就得说头痛头晕，加上呕吐感，偶尔两眼发黑。医生就会安排你去核磁共振。
chicago666
本站元老
- 注册
- 2015-09-07
- 消息
- 7,644
- 荣誉分数
- 1,437
- 声望点数
- 323
我是觉得吧，到底有没有风险，欧洲已经打了那么多了，已经是明摆在那里了。
问题是，前一段时间，疫苗根本不够用，相对于打疫苗的风险，疫情的严重程度不允许挑三拣四的。
现在吧，辉瑞的供应非常充足，咱凭什么不用点风险更低的呢？
问题是，前一段时间，疫苗根本不够用，相对于打疫苗的风险，疫情的严重程度不允许挑三拣四的。
现在吧，辉瑞的供应非常充足，咱凭什么不用点风险更低的呢？
从来没说没风险。意思是好处大于风险
billwanhua
本站元老
- 注册
- 2005-07-07
- 消息
- 16,728
- 荣誉分数
- 5,491
- 声望点数
- 373
全世界都是会叫的孩子有奶喝。
billwanhua
本站元老
- 注册
- 2005-07-07
- 消息
- 16,728
- 荣誉分数
- 5,491
- 声望点数
- 373
你这个话没有问题。现在有其他疫苗，就是风险大于好处了。就像人年轻时要多吃肉，老了肉就变成坏处了。东西还是那个东西，条件变了。
这不是我的。看看每日中午答疑。滚打也是就现状给出的方案。科学家试过了么？
billwanhua
本站元老
- 注册
- 2005-07-07
- 消息
- 16,728
- 荣誉分数
- 5,491
- 声望点数
- 373
Concerns about second vaccine dose amid shortage of AstraZeneca supply
Hundreds of people in Waterloo Region don't know when they'll be able to receive a second dose of the AstraZeneca vaccine due to a supply shortage.
那些打了一针的犯愁了
- 注册
- 2007-01-19
- 消息
- 29,039
- 荣誉分数
- 9,966
- 声望点数
- 373
现在疫苗也不充足，不然也不会3个半月才打第二针。
- 注册
- 2007-01-19
- 消息
- 29,039
- 荣誉分数
- 9,966
- 声望点数
- 373
都是自己的选择，接着打第二针就完了。Concerns about second vaccine dose amid shortage of AstraZeneca supply
Hundreds of people in Waterloo Region don't know when they'll be able to receive a second dose of the AstraZeneca vaccine due to a supply shortage.kitchener.ctvnews.ca
那些打了一针的犯愁了
billwanhua
本站元老
- 注册
- 2005-07-07
- 消息
- 16,728
- 荣誉分数
- 5,491
- 声望点数
- 373
'Very little excuse' to continue to use AstraZeneca in Canada: infectious diseases specialist
It’s time to halt AstraZeneca shots in Canada, except for people 40 or older in hotspots, says Andrew Morris, a doctor on Ontario’s COVID-19 science advisory table
Ontario’s COVID science table, in a brief published Friday, said the risk, based on published estimates, could be as much as one in 26,000.
Morris’ best estimate is that one in 40,000 doses will lead to VITT, a condition that frequently results in complications, with about one in five leading to death and many more cases of severe illness. Given the risk, AstraZeneca only makes sense for those at very high risk of COVID, he said. “But why give them AZ, when we can give them an mRNA vax?”
- 注册
- 2007-01-19
- 消息
- 29,039
- 荣誉分数
- 9,966
- 声望点数
- 373
那些专家“事了拂衣去，深藏身与名” ......
最后编辑:
- 注册
- 2008-05-09
- 消息
- 34,833
- 荣誉分数
- 7,978
- 声望点数
- 373
自己生产疫苗，才是正经事，拿大最应该赶紧上马
- 注册
- 2005-11-23
- 消息
- 30,291
- 荣誉分数
- 7,455
- 声望点数
- 373
1 min ago
The US Centers for Disease Control and Prevention has reports of 28 people who have developed a rare blood clotting syndrome after being given the Johnson & Johnson coronavirus vaccine.
Three people have died, with no additional deaths since the last update in April, the CDC’s Dr. Tom Shimabukuro told a meeting of CDC vaccine advisers Wednesday. He said 8.7 million people have been given the Janssen vaccine.
The CDC has said the condition, thrombosis with thrombocytopenia syndrome (TTS), is plausibly linked to J&J’s Janssen vaccine, but has said the benefits of the vaccine nonetheless outweigh the risk. All cases have been seen in people ages 18 to 59. “Most of the these TTS cases are occurring in the 30-49 year-old age group,” Shimabukuro said.
While most cases were among women, six cases were reported among men, Shimabukuro told the CDC’s Advisory Committee on Immunization Practices. He said 19 had a type of brain blood clot called thrombosis of the cerebral venous sinus, or CVST, while others had different types of blood clots.
The CDC has alerted doctors and the patients about the possibility of the complication so it can be recognized and treated promptly and properly.
“There were no cases with a known or documented coagulation disorder,” Shimabukuro said. That indicates it’s difficult to predict who might develop the condition.
“It is important to recognize TTS early and initiate appropriate treatment,” he added. “TTS is a rare, clinically serious and life-threatening condition.”
CDC reports 28 cases of rare blood clotting among 8.7 million people given Johnson & Johnson vaccine
From CNN's Maggie Fox
The US Centers for Disease Control and Prevention has reports of 28 people who have developed a rare blood clotting syndrome after being given the Johnson & Johnson coronavirus vaccine.
Three people have died, with no additional deaths since the last update in April, the CDC’s Dr. Tom Shimabukuro told a meeting of CDC vaccine advisers Wednesday. He said 8.7 million people have been given the Janssen vaccine.
The CDC has said the condition, thrombosis with thrombocytopenia syndrome (TTS), is plausibly linked to J&J’s Janssen vaccine, but has said the benefits of the vaccine nonetheless outweigh the risk. All cases have been seen in people ages 18 to 59. “Most of the these TTS cases are occurring in the 30-49 year-old age group,” Shimabukuro said.
While most cases were among women, six cases were reported among men, Shimabukuro told the CDC’s Advisory Committee on Immunization Practices. He said 19 had a type of brain blood clot called thrombosis of the cerebral venous sinus, or CVST, while others had different types of blood clots.
The CDC has alerted doctors and the patients about the possibility of the complication so it can be recognized and treated promptly and properly.
“There were no cases with a known or documented coagulation disorder,” Shimabukuro said. That indicates it’s difficult to predict who might develop the condition.
“It is important to recognize TTS early and initiate appropriate treatment,” he added. “TTS is a rare, clinically serious and life-threatening condition.”